发明名称 |
INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID |
摘要 |
PROBLEM TO BE SOLVED: To develop a novel formulation exhibiting high stability and drug stability.SOLUTION: An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus.SELECTED DRAWING: Figure 8 |
申请公布号 |
JP2016172774(A) |
申请公布日期 |
2016.09.29 |
申请号 |
JP20160133094 |
申请日期 |
2016.07.05 |
申请人 |
CYDEX PHARMACEUTICALS INC |
发明人 |
PIPKIN JAMES D;ZIMMERER PUPERT O;THOMPSON DIANE O;MOSHER GEROLD L |
分类号 |
A61K31/57;A61K9/00;A61K9/08;A61K9/12;A61K9/14;A61K31/16;A61K31/58;A61K31/715;A61K47/40;A61K47/48;A61P11/06;A61P29/00;C08B37/16 |
主分类号 |
A61K31/57 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|